Naaju Breaking News, Live Updates, Latest Headlines, Viral News, Top Stories, Trending Topics, Videos
[ad_1]
In what could be considered an important step towards fight against the coronavirus pandemic in South America, Brazil I received this Thursday a first batch with 120,000 doses of CoronaVac vaccine, which is being developed by the Chinese laboratory Sinovac Biotech, as announced by the government of Sao Paulo.
“This is a very important step,” said the governor of São Paulo. Joao doria, who was today with his Secretary of Health, Jean Gorinchteyn, and the director of the Butantan Institute, Dimas Covas, at Guarulhos International Airport when the plane from China that brought the batch of the dose landed.
“This is the vaccine that will help save the lives of millions of Brazilians,” said Doria, who also argued that Over the next month, “6 million more doses” will reach this state to start with mass vaccination plans
The vaccine, which arrived in Brazil as part of an agreement with the Butantan Institute and attached to the government of Sao Paulo, has become a reason dispute between the far-right president Jair Bolsonaro and Doria, his former ally and current political rival.
The confrontation intensified last week, when the national health surveillance agency (Anvisa) suspended for 48 hours the trial among volunteers in Brazil, arguing “a serious incident” occurred during testing. Bolsonaro congratulated on social networks for stopping the study, and the regional authorities of Sao Paulo, as well as the directive of the Butantan Institute, expressed their “indignation” and guaranteed that the incident was not related to the drug under investigation.
The suicide of a test volunteer led to the suspension of the tests but, immediately, Anvisa authorized their takeover, after stating that study suspensions are common and that “does not necessarily mean that the product under investigation is not of quality, safe or effective”.
The agreement between Sinovac and the Butantan Institute envisages shipment of a total of 6 million doses until the end of the year, as well as the delivery of raw materials to manufacture an additional 40 million doses in Sao Paulo, according to the regional government. Authorization from Anvisa required for vaccine application in Brazil, news agency reported Tlam.
CoronaVac is one of the most advanced vaccines in the world, very close to the American pharmaceutical giant Pfizer, since it is also in phase 3 human trials, the last step before its approval and which involves thousands of volunteers in Brazil, Indonesia and Turkey.
Brazil, second country with the most deaths in the world, has more than 167,000 deaths and nearly 6 million infected with the new virus. In recent days, there has been an increase in infections and deaths, which some researchers attribute to the news of a second wave.
Sao Paulo, the country’s most populous state and the most affected, has recorded more than 1.1 million cases and nearly 41,000 deaths from the disease.
.
[ad_2]
Source link
